
HTGC
Hercules Capital Inc
- Overview
- Forecast
- Valuation
- Earnings

Line
|

Candle
1D
5D
1M
3M
6M
YTD
1Y
5Y
High
19.380
Open
19.180
VWAP
19.26
Vol
975.94K
Mkt Cap
3.49B
Low
19.1604
Amount
18.79M
EV/EBITDA(TTM)
16.01
Total Shares
162.18M
EV
5.49B
EV/OCF(TTM)
--
P/S(TTM)
7.66
Hercules Capital, Inc. is a specialty finance company. The Company is focused on providing financing solutions to venture capital-backed and institutional-backed companies in a variety of technology and life sciences industries. It is structured as an internally managed, non-diversified, closed-end investment company. Its business objectives are to increase its net income, net investment income, and net asset value, through its investments in primarily structured debt or senior secured debt instruments of venture capital-backed and institutional-backed companies across a variety of technology-related industries at attractive yields. It invests in a range of companies active in the technology industry sub-sectors characterized by products or services that require advanced technologies, including computer software and hardware, networking systems, semiconductors, telecommunications equipment and media, semiconductor capital equipment, information technology infrastructure and others.
Show More
Market Estimates
Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2026Q1
FY2025Q4
FY2025Q3
142.30M
+19.07%
0.494
+9.88%
139.71M
+14.72%
0.492
+0.35%
136.95M
+9.35%
0.484
-5.17%
Estimates Revision
The market is revising Downward the revenue expectations for Hercules Capital, Inc. (HTGC) for FY2025, with the revenue forecasts being adjusted by -0.2% over the past three months. During the same period, the stock price has changed by 10.52%.
Revenue Estimates for FY2025
Revise Downward

-0.2%
In Past 3 Month
EPS Estimates for FY2025
Revise Downward

-0.21%
In Past 3 Month
Stock Price
Go Up

+10.52%
In Past 3 Month
4 Analyst Rating

8.22% Upside
Wall Street analysts forecast HTGC stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for HTGC is 20.81 USD with a low forecast of 19.00 USD and a high forecast of 24.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
2 Buy
2 Hold
0 Sell
Moderate Buy

8.22% Upside
Current: 19.230

Low
19.00
Averages
20.81
High
24.00

8.22% Upside
Current: 19.230

Low
19.00
Averages
20.81
High
24.00
Citizens JMP
Devin Ryan
Outperform
maintain
$22 -> $24
2025-08-04
Reason
Citizens JMP
Devin Ryan
Price Target
$22 -> $24
2025-08-04
maintain
Outperform
Reason
Citizens JMP analyst Devin Ryan raised the firm's price target on Hercules Capital to $24 from $22 and keeps an Outperform rating on the shares following the earnings report. Best in class fundamentals and scaling RIA have created a "unique" buying opportunity in Hercules Capital, the analyst tells investors in a research note. The firm sees a strong trajectory for Hercules to appreciate back to the low-to-mid $20s over the next several quarters.
Piper Sandler
Overweight
maintain
$20 -> $21
2025-08-01
Reason
Piper Sandler
Price Target
$20 -> $21
2025-08-01
maintain
Overweight
Reason
Piper Sandler raised the firm's price target on Hercules Capital to $21 from $20 and keeps an Overweight rating on the shares. The firm notes Hercules posted a beat versus PSC and the Street and had a record quarter of originations. Piper views the results as very strong in the current environment with continued momentum in investment activity and improving credit.
UBS
Doug Harter
Neutral
maintain
$19
2025-07-16
Reason
UBS
Doug Harter
Price Target
$19
2025-07-16
maintain
Neutral
Reason
UBS analyst Doug Harter raised the firm's price target on Hercules Capital to $19 from $18.50 and keeps a Neutral rating on the shares.
UBS
Vilas Abraham
Hold
Maintains
$20 → $18
2025-04-17
Reason
UBS
Vilas Abraham
Price Target
$20 → $18
2025-04-17
Maintains
Hold
Reason
UBS lowered the firm's price target on Hercules Capital to $18 from $20 and keeps a Neutral rating on the shares as part of a Q1 earnings preview for the business development companies. The focus for investors during earnings will be on the outlook for credit quality given the increased economic uncertainty, the analyst tells investors in a research note. The firm says that while the pullback in the sector has made valuations more attractive, the overhang from credit quality concerns and earnings drag from lower short-term rates will persist. UBS cut price targets to reflect a lower return on equity outlook from slower loan growth and lower target multiples given increased economic uncertainty.
Piper Sandler
Crispin Love
Buy
Maintains
$23 → $20
2025-04-08
Reason
Piper Sandler
Crispin Love
Price Target
$23 → $20
2025-04-08
Maintains
Buy
Reason
Piper Sandler analyst Crispin Love lowered the firm's price target on Hercules Capital to $20 from $23 and keeps an Overweight rating on the shares. The firm notes asset managers have underperformed financials and the broader market in 2025-to-date, and in recent days, following outperformance in 2024. Sentiment and the outlook have shifted dramatically in what was initially believed to be an environment primed for alternative asset managers for deal activity and realizations following the Trump election to one that is now grappling with tariffs, a potential recession and a capital markets window slamming shut, Piper argues. Unfortunately, given the fluidity of the current environment "we will likely finish 1Q25 earnings season with more questions than answers with uncertainty in current policy and impacts to the macro and asset managers unclear," Piper says.
Keefe, Bruyette & Woods
Paul Johnson
Buy
Maintains
$22 → $21
2025-04-08
Reason
Keefe, Bruyette & Woods
Paul Johnson
Price Target
$22 → $21
2025-04-08
Maintains
Buy
Reason
Keefe Bruyette lowered the firm's price target on Hercules Capital to $20.50 from $21.50 and keeps an Outperform rating on the shares.
See All Ratings
Valuation Metrics
The current forward P/E ratio for Hercules Capital Inc (HTGC.N) is 9.75, compared to its 5-year average forward P/E of 9.82. For a more detailed relative valuation and DCF analysis to assess Hercules Capital Inc 's fair value, click here.
Forward PE
The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

Fair
5Y Average PE
9.82
Current PE
9.75
Overvalued PE
11.82
Undervalued PE
7.82
Forward EV/EBITDA
The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

N/A
5Y Average EV/EBITDA
0.00
Current EV/EBITDA
0.00
Overvalued EV/EBITDA
0.00
Undervalued EV/EBITDA
0.00
Forward PS
The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

Fair
5Y Average PS
5.65
Current PS
6.09
Overvalued PS
6.56
Undervalued PS
4.74
Financials
Annual
Quarterly
FY2025Q2
YoY :
+51.04%
127.63M
Total Revenue
FY2025Q2
YoY :
+66.91%
101.84M
Operating Profit
FY2025Q2
YoY :
+88.49%
78.89M
Net Income after Tax
FY2025Q2
YoY :
+72.00%
0.43
EPS - Diluted
FY2025Q2
YoY :
-345.02%
-144.84M
Free Cash Flow
FY2025Q2
YoY :
+0.65%
97.85
Gross Profit Margin - %
FY2025Q2
YoY :
+85.80%
-70.14
FCF Margin - %
FY2025Q2
YoY :
+24.79%
61.81
Net Margin - %
Trading Trends
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
7.0K
USD
1
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
2.0M
USD
1
Bought
0-3
1
7.0K
USD
Months
3-6
6
555.9K
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
0-3
Months
0.0
Volume
0
3-6
Months
25.0K
Volume
1
6-9
Months
0.0
Volume
0
0-12
Months
0.0
Volume
0
Bought
0-3
0
0.0
Volume
Months
3-6
0
0.0
Volume
Months
6-9
1
28.3K
Volume
Months
0-12
0
0.0
Volume
Months
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
4
32.0K
USD
Months
6-9
0
0.0
USD
Months
0-12
4
81.0K
USD
Months
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
7.0K
USD
1
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
2.0M
USD
1
Bought
0-3
1
7.0K
USD
Months
3-6
6
555.9K
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
HTGC News & Events
Events Timeline
2025-08-08 (ET)
2025-08-08
07:49:51
Heron Therapeutics announces capital restructuring

2025-07-31 (ET)
2025-07-31
16:09:24
Hercules Capital reports Q2 NII 50c, consensus 47c

2025-05-13 (ET)
2025-05-13
07:30:00
Altimmune secures up to $100M in credit facility

Sign Up For More Events
Sign Up For More Events
News
8.0
08-08NASDAQ.COMReminder - Hercules Technology Growth Capital (HTGC) Goes Ex-Dividend Soon
8.5
08-08PRnewswireHeron Therapeutics Announces Comprehensive Capital Restructuring to Support Growth and Extend Maturity Profile
8.5
08-05NASDAQ.COMSnappt Acquires Trigo To Bolster Rental Verification, Secures $50 Mln From Hercules Capital
Sign Up For More News
People Also Watch

CRNX
Crinetics Pharmaceuticals Inc
30.920
USD
+5.17%

CLSK
CleanSpark Inc
9.820
USD
+5.25%

USLM
United States Lime & Minerals Inc
121.520
USD
+6.33%

CRSP
CRISPR Therapeutics AG
54.320
USD
+2.84%

SSL
Sasol Ltd
6.290
USD
+4.14%

ESE
ESCO Technologies Inc
195.290
USD
+2.49%

GPOR
Gulfport Energy Corp
168.910
USD
+0.28%

RNA
Avidity Biosciences Inc
46.350
USD
+3.78%
FAQ

What is Hercules Capital Inc (HTGC) stock price today?
The current price of HTGC is 19.23 USD — it has increased 0.42 % in the last trading day.

What is Hercules Capital Inc (HTGC)'s business?

What is the price predicton of HTGC Stock?

What is Hercules Capital Inc (HTGC)'s revenue for the last quarter?

What is Hercules Capital Inc (HTGC)'s earnings per share (EPS) for the last quarter?

What changes have occurred in the market's expectations for Hercules Capital Inc (HTGC)'s fundamentals?

How many employees does Hercules Capital Inc (HTGC). have?
